Nebraska 2022 Session Status: Introduced

LB753 — The official site of the Nebraska Unicameral Legislature

Last action — Provisions/portions of LB753 amended into LB752 by AM1918

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Legislature
  4. 4
    To Executive
  5. 5
    Enacted

This bill died with 2022 Session. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Require health care practitioners to provide notification regarding stem cell therapy

Bill Text

We don't have the full text on file for this bill yet.

Read LB753 on the official Nebraska source →

Action History

  1. Date of introduction

  2. Referred to Health and Human Services Committee

  3. Notice of hearing for January 21, 2022

  4. Hilkemann name added

  5. Indefinitely postponed

  6. Provisions/portions of LB753 amended into LB752 by AM1918

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 48 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (48)

48 members have not signed on to this bill.

Show all 48 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does LB753 do?
Require health care practitioners to provide notification regarding stem cell therapy
Who sponsors LB753?
LB753 is sponsored by John Arch.
What is the current status of LB753?
This bill died with 2022 Session. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track LB753?
Track LB753 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on LB753

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of LB753

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →